Quidel Lyra Direct C.difficile Assay - Taiwan Registration e794d665f4cf27d33645e927d86e9dff
Access comprehensive regulatory information for Quidel Lyra Direct C.difficile Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e794d665f4cf27d33645e927d86e9dff and manufactured by QUIDEL CORPORATION. The authorized representative in Taiwan is BIO-CHECK LABORATORIES LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
e794d665f4cf27d33645e927d86e9dff
Ministry of Health Medical Device Import No. 030538
DHA05603053803
Product Details
This product was tested as a multi-standard quantitative detection reagent, which showed the toxin A gene (tcdA) and toxin B gene (tcdB) of Clostridium difficile to assist in the diagnosis of Clostridium difficile related diseases (CDAD).
C Immunology and microbiology devices
C3130 ๅฐ้ฃๆขญ็ๆกฟ่ๆฏ็ด (ClostridiumDifficileToxin)ๅบๅ ๆดๅข่ฉฆๅ
Imported from abroad
Dates and Status
Apr 14, 2018
Apr 14, 2023